Posts

The Four Psychedelics ETFs Capturing Investor Attention
Business, NewsDespite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and size. This leads them to having different sized stakes companies, and their long-term success...

Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis
Business, Editorial, NewsOur resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.

Understanding 3 Risks of Investing in Psychedelic Stocks
Business, EditorialNo one is responsible for your financial future, other than yourself, so be responsible with your money.

Interested in Psychedelic Stocks? This Is the BEST Resource for You
BusinessIntroducing the Benzinga Psychedelics Capital Conference on April 19 in Miami Beach,

Is Small Pharma a Good Psychedelic Stock Investment?
Business, EditorialOur resident Psychedelic Investor James Hallifax looks at the pros and cons of this Canadian-based company developing DMT for therapeutic use.

Is Wall Street the Next Stop for Psychedelics? Investing in the Psychedelic Medicine Sector
BusinessElemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future of the psychedelics market in this guest blog.

How Long Until Psychedelic Stocks Payoff?
Business, EditorialOur resident Psychedelic Investor explores one of the biggest questions on minds of those investing in psychedelic stocks.

4 Tips for Investing in Psychedelic Stocks During a Market Downturn
Business, InvestingFriendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a phoenix or burn to the ground.

Why Psychedelic Stocks Have Crashed in the Last 3 Months
BusinessOur resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.